Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
New York, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Online fraud is climbing at a rapid pace, with e-commerce and financial services platforms facing the greatest impact, according to Veriff’s newly...
Read More -
Matisse Pharmaceuticals receives INN (International Non-proprietary Name) isupartob sodium from the WHO recognizing first-in-class drug status for M6229.
Read More
-
Authorization Covers Multiple Screening Tests for Cancer and Chronic Disease Risk Detection • Portfolio includes tests for colorectal disease, breast self exam, prostate disease, kidney disease, and...
-
Synopsys, Inc. Stock Dropped 36% on IP Underperformance; Contact BFA Law about the Pending Securities Class Action
-
MoonLake Immunotherapeutics Stock Dropped 90% after Drug Trial Results; Contact BFA Law about the Pending Securities Class Action
-
Freeport-McMoRan Inc. Stock Dropped 25% after Safety Issues; Contact BFA Law about the Pending Securities Class Action
-
Inspire Medical Systems, Inc. Stock Dropped 32% on Inspire V Delays; Contact BFA Law about the Pending Securities Class Action
-
Alexandria Real Estate Equities, Inc. Stock Dropped 19% on Impairment Charge Announcement; Contact BFA Law about the Pending Securities Class Action
-
James Hardie Industries Stock Dropped 34% on Destocking Issues and CFO Departure; Contact BFA Law about the Pending Securities Class Action
-
Dublin, Dec. 11, 2025 (GLOBE NEWSWIRE) -- The "Sprinkler Hose Market - Global Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering. The sprinkler hose market represents a...
-
Novel first-in-class therapeutic targeting a key immune signaling pathway and the underlying cause of HITIt is the first and only potent, highly selective inhibitor of human 12-LOX in clinical...
-
60 Degrees Pharmaceuticals will expand ARAKODA sales in 2026 with more reps, a GoodRx partnership, enhanced digital marketing, and added babesiosis trials